iSAM Funds (UK)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $410K | Buy |
+3,259
| New | +$410K | 0.09% | 305 |
|
|
2024
Q3 | – | Sell |
-1,701
| Closed | -$234K | – | 368 |
|
|
2024
Q2 | $234K | Buy |
+1,701
| New | +$234K | 0.18% | 195 |
|
|
2023
Q3 | – | Sell |
-4,745
| Closed | -$447K | – | 303 |
|
|
2023
Q2 | $447K | Buy |
+4,745
| New | +$447K | 0.4% | 106 |
|